Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16219716rdf:typepubmed:Citationlld:pubmed
pubmed-article:16219716lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16219716lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:16219716lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:16219716lifeskim:mentionsumls-concept:C1709457lld:lifeskim
pubmed-article:16219716lifeskim:mentionsumls-concept:C0027530lld:lifeskim
pubmed-article:16219716lifeskim:mentionsumls-concept:C0040123lld:lifeskim
pubmed-article:16219716lifeskim:mentionsumls-concept:C1522577lld:lifeskim
pubmed-article:16219716lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:16219716lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:16219716lifeskim:mentionsumls-concept:C0041618lld:lifeskim
pubmed-article:16219716lifeskim:mentionsumls-concept:C1520142lld:lifeskim
pubmed-article:16219716pubmed:issue1lld:pubmed
pubmed-article:16219716pubmed:dateCreated2006-1-10lld:pubmed
pubmed-article:16219716pubmed:abstractTextAlthough the prognosis of papillary thyroid microcarcinoma (PTMC) is usually excellent, the optimal follow-up strategy has never been investigated.lld:pubmed
pubmed-article:16219716pubmed:languageenglld:pubmed
pubmed-article:16219716pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16219716pubmed:citationSubsetAIMlld:pubmed
pubmed-article:16219716pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16219716pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16219716pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16219716pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16219716pubmed:statusMEDLINElld:pubmed
pubmed-article:16219716pubmed:monthJanlld:pubmed
pubmed-article:16219716pubmed:issn0021-972Xlld:pubmed
pubmed-article:16219716pubmed:authorpubmed-author:TrischittaVin...lld:pubmed
pubmed-article:16219716pubmed:authorpubmed-author:Di...lld:pubmed
pubmed-article:16219716pubmed:authorpubmed-author:FilettiSebast...lld:pubmed
pubmed-article:16219716pubmed:authorpubmed-author:ModoniSergioSlld:pubmed
pubmed-article:16219716pubmed:authorpubmed-author:TorlontanoMas...lld:pubmed
pubmed-article:16219716pubmed:authorpubmed-author:CrocettiUmber...lld:pubmed
pubmed-article:16219716pubmed:authorpubmed-author:D'AloisoLeona...lld:pubmed
pubmed-article:16219716pubmed:authorpubmed-author:BonfittoNazar...lld:pubmed
pubmed-article:16219716pubmed:authorpubmed-author:FruscianteVin...lld:pubmed
pubmed-article:16219716pubmed:authorpubmed-author:BrunoRoccoRlld:pubmed
pubmed-article:16219716pubmed:authorpubmed-author:AugelloGiovan...lld:pubmed
pubmed-article:16219716pubmed:authorpubmed-author:VarrasoAntoni...lld:pubmed
pubmed-article:16219716pubmed:authorpubmed-author:DicembrinoFra...lld:pubmed
pubmed-article:16219716pubmed:issnTypePrintlld:pubmed
pubmed-article:16219716pubmed:volume91lld:pubmed
pubmed-article:16219716pubmed:ownerNLMlld:pubmed
pubmed-article:16219716pubmed:authorsCompleteYlld:pubmed
pubmed-article:16219716pubmed:pagination60-3lld:pubmed
pubmed-article:16219716pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16219716pubmed:meshHeadingpubmed-meshheading:16219716...lld:pubmed
pubmed-article:16219716pubmed:meshHeadingpubmed-meshheading:16219716...lld:pubmed
pubmed-article:16219716pubmed:meshHeadingpubmed-meshheading:16219716...lld:pubmed
pubmed-article:16219716pubmed:meshHeadingpubmed-meshheading:16219716...lld:pubmed
pubmed-article:16219716pubmed:meshHeadingpubmed-meshheading:16219716...lld:pubmed
pubmed-article:16219716pubmed:meshHeadingpubmed-meshheading:16219716...lld:pubmed
pubmed-article:16219716pubmed:meshHeadingpubmed-meshheading:16219716...lld:pubmed
pubmed-article:16219716pubmed:meshHeadingpubmed-meshheading:16219716...lld:pubmed
pubmed-article:16219716pubmed:meshHeadingpubmed-meshheading:16219716...lld:pubmed
pubmed-article:16219716pubmed:meshHeadingpubmed-meshheading:16219716...lld:pubmed
pubmed-article:16219716pubmed:meshHeadingpubmed-meshheading:16219716...lld:pubmed
pubmed-article:16219716pubmed:meshHeadingpubmed-meshheading:16219716...lld:pubmed
pubmed-article:16219716pubmed:meshHeadingpubmed-meshheading:16219716...lld:pubmed
pubmed-article:16219716pubmed:meshHeadingpubmed-meshheading:16219716...lld:pubmed
pubmed-article:16219716pubmed:meshHeadingpubmed-meshheading:16219716...lld:pubmed
pubmed-article:16219716pubmed:year2006lld:pubmed
pubmed-article:16219716pubmed:articleTitleComparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy.lld:pubmed
pubmed-article:16219716pubmed:affiliationUnits of Endocrinology, Istituto di Ricovero e Cura a Carattere Scientifico Casa Sollievo della Sofferenza, 71013 S. Giovanni Rotondo, Italy. m.torlontano@tin.itlld:pubmed
pubmed-article:16219716pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16219716pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:16219716pubmed:publicationTypeComparative Studylld:pubmed